Sialylated fetuin-A as a marker of immunotherapy efficacy
US10884002B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 2015 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Aug 8, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the identification of specific polypeptides, fragments variants thereof which can be used as markers for the efficacy of immunotherapy, particular for predicting responsiveness of a patient to immunotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.